Trident Lifeline Limited (BSE: 543616)
Health Care · Pharmaceuticals · IN
Rs282.45
+7.07% today · +0.5% 1Y
Trident Lifeline Limited (BSE: 543616) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $35.23M.
Over the last twelve months the share price has gained 0.5%, trading between 229.95 and 328.00.
Tweenvest scores Trident Lifeline Limited across four factors: quality 59/100, value 72/100. Its strongest factor is value.
543616 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $35.23M
- Revenue (TTM)
- $14.72M
- P/E
- 15.78
- EPS
- 17.90
- Dividend yield
- —
- Beta (5Y)
- -0.26
- 52-week high
- Rs328.00
- 52-week low
- Rs229.95
- Avg volume (3M)
- —
- Shares outstanding
- 11.93M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.